Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion type Assertion NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_head.
- NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion description "[Overall results suggest that phosphorylated HER3, ERK1/2 and p53 may be used as biomarkers to determine the sensitivity of bladder cancers to TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_provenance.
- NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion evidence source_evidence_literature NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_provenance.
- NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion SIO_000772 25482142 NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_provenance.
- NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion wasDerivedFrom befree-2016 NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_provenance.
- NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_assertion wasGeneratedBy ECO_0000203 NP1245533.RA1Te_k3YsAJ1I1F4OCiI7_BCY_EJO5bF0b9PaJG0JGn4130_provenance.